Sun Pharma is a leading global pharmaceutical company providing high-quality medicines to patients and healthcare professionals in more than 100 countries. It has six R&D centers and more than 40 manufacturing facilities across the globe. Our business is vertically integrated - from research to manufacturing Active Pharmaceutical Ingredients to formulation production. We invest approximately 6-7% of our global revenue into R&D to deliver medicines that patients can trust.
Japan is one of the most important markets which Sun Pharma is committed to. In Japan, Sun Pharma has been developing its specialty business with a focus on the dermatology field, which is one of our strengths, and offering high-quality medicines, including new biologics.
We will continue to do our utmost to further contribute to patients and their families, as well as doctors and other healthcare professionals, by providing a stable supply of high-quality medicines. We appreciate your continued support.
Shoichiro Ogawa